Recent Activity

Loading...

HLVX

HilleVax, Inc · NASDAQ

Performance

+4.59%

1W

-4.34%

1M

-8.01%

3M

+9.63%

6M

-13.46%

YTD

-2.18%

1Y

Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Investment Analysis Report: HLVX

Overview:

HLVX is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $742.54 million. In this report, we will conduct a comprehensive analysis of HLVX focusing on various perspectives including Valuation, Financial Health, Ea...

See more ...

Technical Analysis of HLVX 2024-05-03

Overview:

In analyzing the technical indicators for HLVX over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...

See more ...

Recent News & Updates